Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects

NCT02472236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PEX168
DRUG: Digoxin

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.